These results suggest that under hyperglycaemia condition, enhanced IL‐10 level is an adaptive response to resist the body's inflammation, and FGF1 administration further promotes the secretion of anti‐inflammatory cytokines (IL‐10). The gene discussed is IL10; the disease is Hyperglycemia.